Explore 3 Stock Ideas & Industry Insights Download Free Report

8082-737-676
Shopping Cart 0
countryflagUK
Login

CVS Health Corp

Healthcare US CVS

101.96USD
1.48(1.47%)

Last update at 2026-06-12T20:25:00Z

Day Range

100.01102.77
LowHigh

52 Week Range

56.7984.46
LowHigh

Fundamentals

  • Previous Close 100.48
  • Market Cap99144.92M
  • Volume11091949
  • P/E Ratio55.65
  • Dividend Yield3.47%
  • EBITDA14625.00M
  • Revenue TTM399833.99M
  • Revenue Per Share TTM315.57
  • Gross Profit TTM 53129.00M
  • Diluted EPS TTM1.39

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax 2136.00M 6148.00M 11173.00M 5628.00M 10420.00M
Minority interest 40.00M 28.00M -24.00000M 16.00M -12.00000M
Net income 1768.00M 4614.00M 8344.00M 4311.00M 7910.00M
Selling general administrative 970.00M 40240.00M 38360.00M 745.00M 36934.00M
Selling and marketing expenses - 989.00M 985.00M - -
Gross profit 55362.00M 51401.00M 54431.00M 54294.00M 52048.00M
Reconciled depreciation 4606.00M 4597.00M 4366.00M 4247.00M 4512.00M
Ebit 5255.00M 9086.00M 13743.00M 16251.00M 13193.00M
Ebitda 9861.00M 13683.00M 13743.00M 20498.00M 19676.00M
Depreciation and amortization 4606.00M 4597.00M 4366.00M 4247.00M 6483.00M
Non operating income net other - - - 169.00M -270.00000M
Operating income 10385.00M 8516.00M 13743.00M 16251.00M 13193.00M
Other operating expenses 391682.00M 364293.00M 600963.00M 306385.00M 277129.00M
Interest expense 3119.00M 2958.00M 2658.00M 2287.00M 2503.00M
Tax provision 408.00M 1562.00M 2805.00M 1463.00M 2522.00M
Interest income 3119.00M 2958.00M 2658.00M 2287.00M 2503.00M
Net interest income -3119.00000M -2958.00000M -2658.00000M -2287.00000M -2503.00000M
Extraordinary items - - - 0.00000M 0.00000M
Non recurring - - - 8336.00M 431.00M
Other items - - - - -
Income tax expense 408.00M 1562.00M 2805.00M 1463.00M 2522.00M
Total revenue 402067.00M 372809.00M 357776.00M 322467.00M 292111.00M
Total operating expenses 44977.00M 42885.00M 39832.00M 38212.00M 37066.00M
Cost of revenue 346705.00M 321408.00M 303345.00M 268173.00M 240063.00M
Total other income expense net -8249.00000M -2368.00000M -2570.00000M -10623.00000M -2773.00000M
Discontinued operations - - - - -
Net income from continuing ops 1728.00M 4586.00M 8368.00M 4165.00M 7898.00M
Net income applicable to common shares 1768.00M 4614.00M 8344.00M 4149.00M 7910.00M
Preferred stock and other adjustments - - - - -
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 261064.00M 253215.00M 249728.00M 228275.00M 232999.00M
Intangible assets 25508.00M 27323.00M 29234.00M 24754.00M 29026.00M
Earning assets - - - - -
Other current assets 5032.00M 3076.00M 3151.00M 2685.00M 5292.00M
Total liab 185682.00M 177485.00M 173092.00M 156960.00M 157618.00M
Total stockholder equity 75214.00M 75560.00M 76461.00M 71015.00M 75075.00M
Deferred long term liab - - - 3880.00M 6270.00M
Other current liab 23441.00M 61223.00M 59579.00M 47562.00M 5604.00M
Common stock 18.00M 18.00M 48992.00M 48193.00M 47377.00M
Capital stock 50402.00M 49661.00M 48992.00M 48193.00M 47377.00M
Retained earnings 61196.00M 62837.00M 61604.00M 56145.00M 54906.00M
Other liab - - - 19948.00M 19663.00M
Good will 85478.00M 91272.00M 91272.00M 78150.00M 79121.00M
Other assets 7113.00M 8104.00M 7910.00M 7604.00M 9801.00M
Cash 8512.00M 8586.00M 8196.00M 12945.00M 9408.00M
Cash and equivalents 8453.00M 8586.00M 8196.00M 12945.00M 9408.00M
Total current liabilities 88692.00M 84609.00M 79189.00M 69736.00M 67807.00M
Current deferred revenue 62.00M - 57112.00M 3880.00M 43808.00M
Net debt 85081.00M 74334.00M 71189.00M 57787.00M 66591.00M
Short term debt 5805.00M 7494.00M 4713.00M 3456.00M 5851.00M
Short long term debt 4068.00M 5743.00M 2972.00M 1778.00M 4205.00M
Short long term debt total 93593.00M 82920.00M 79385.00M 70732.00M 75999.00M
Other stockholder equity 13594.00M 12825.00M -33838.00000M -31858.00000M -28173.00000M
Property plant equipment 28056.00M 28937.00M 30435.00M 12873.00M 12896.00M
Total current assets 74714.00M 68645.00M 67858.00M 65682.00M 60008.00M
Long term investments 32669.00M 28934.00M 23019.00M 21096.00M 23025.00M
Net tangible assets - - - 71015.00M -33072.00000M
Short term investments 2145.00M 2407.00M 3259.00M 2778.00M 3117.00M
Net receivables 39779.00M 36469.00M 35227.00M 27276.00M 24431.00M
Long term debt 60502.00M 60527.00M 58638.00M 50476.00M 51971.00M
Inventory 19246.00M 18107.00M 18025.00M 19090.00M 17760.00M
Accounts payable 59384.00M 15892.00M 14897.00M 14838.00M 12544.00M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - 300.00M 306.00M
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income 406.00M -120.00000M -297.00000M -1465.00000M 965.00M
Additional paid in capital - - - - -
Common stock total equity - - - 48193.00M 47377.00M
Preferred stock total equity - - - - -
Retained earnings total equity - - - 56145.00M 54906.00M
Treasury stock - - - -31858.00000M -28173.00000M
Accumulated amortization - - - - -
Non currrent assets other 6913.00M 8104.00M 7910.00M 3968.00M 4714.00M
Deferred long term asset charges - - - - -
Non current assets total 186350.00M 184570.00M 181870.00M 162593.00M 172991.00M
Capital lease obligations 15380.00M 16650.00M 17775.00M 18478.00M 19823.00M
Long term debt total 60502.00M 60527.00M 58638.00M 50476.00M 51971.00M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments -2629.00000M -7613.00000M -19766.00000M -1017.00000M -2717.00000M
Change to liabilities - - - 4260.00M 5919.00M
Total cashflows from investing activities -5871.00000M -7613.00000M -20889.00000M -5047.00000M -5261.00000M
Net borrowings -1779.00000M 5059.00M 7932.00M -4211.00000M -9267.00000M
Total cash from financing activities -4940.00000M -1135.00000M 2683.00M -10516.00000M -11356.00000M
Change to operating activities - - - 7149.00M 3018.00M
Net income 1768.00M 4586.00M 8368.00M 4165.00M 7898.00M
Change in cash -172.00000M 359.00M -4780.00000M 614.00M 1648.00M
Begin period cash flow 8884.00M 8525.00M 13305.00M 12691.00M 11043.00M
End period cash flow 8712.00M 8884.00M 8525.00M 13305.00M 12691.00M
Total cash from operating activities 10639.00M 9107.00M 13426.00M 16177.00M 18265.00M
Issuance of capital stock - - - - -
Depreciation 4606.00M 4597.00M 4366.00M 4247.00M 4512.00M
Other cashflows from investing activities 26.00M 101.00M 68.00M -1303.00000M -24.00000M
Dividends paid 3397.00M 3373.00M 3132.00M 2907.00M 2625.00M
Change to inventory -1267.00000M -102.00000M 1233.00M -1435.00000M 735.00M
Change to account receivables -3498.00000M -1301.00000M -6260.00000M -2971.00000M -2703.00000M
Sale purchase of stock 394.00M -3023.00000M -2012.00000M -3500.00000M 549.00M
Other cashflows from financing activities 1961.00M 202.00M -105.00000M -449.00000M 1523.00M
Change to netincome - - - 2533.00M 549.00M
Capital expenditures 2832.00M 2781.00M 3031.00M 2727.00M 2520.00M
Change receivables - - - 2971.00M -2703.00000M
Cash flows other operating - - - 16177.00M 1355.00M
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - 614.00M 1648.00M
Change in working capital -1474.00000M 109.00M 15.00M 7003.00M 3948.00M
Stock based compensation 535.00M 540.00M 588.00M 447.00M 484.00M
Other non cash items 10345.00M -153.00000M 765.00M 2390.00M 1851.00M
Free cash flow 7807.00M 6326.00M 10395.00M 13450.00M 15745.00M

Peer Comparison

Sector: Healthcare Industry: Healthcare Plans

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
CVS
CVS Health Corp		 1.48 1.47% 101.96 55.65 10.80 0.25 1.32 0.42 17.09
UNH
UnitedHealth Group Incorporated		 2.97 0.73% 408.52 22.57 18.38 1.33 5.65 1.38 13.97
CI
Cigna Corp		 3.16 1.07% 298.00 12.47 9.12 0.27 1.75 0.35
ELV
Elevance Health Inc		 4.89 1.23% 404.07 13.02 12.47 0.36 1.60 0.47
HUM
Humana Inc		 10.53 2.86% 379.22 19.16 14.60 0.56 3.37 0.53

Reports Covered

Stock Research & News

View All

Profile

CVS Health Corporation provides health solutions in the United States. The company operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, medical management capabilities, Medicare Advantage and Medicare Supplement plans, PDPS and Medicaid health care management services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The Health Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, specialty and mail order pharmacy, clinical, disease management, medical spend management services, pharmacy and other administrative services. It serves employers, insurance companies, unions, government employee groups, health plans, PDPS, Medicaid managed care plans, CMS, plans offered on public health insurance, and other sponsors of health benefit plans. The Pharmacy & Consumer Wellness segment sells prescription and over-the-counter drugs, consumer health and beauty products, personal care products, and other general merchandise products. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. It operates online retail pharmacy websites, retail specialty pharmacy stores, compounding pharmacies and branches for infusion and enteral nutrition services. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1963 and is headquartered in Woonsocket, Rhode Island.

CVS Health Corp

One CVS Drive, Woonsocket, RI, United States, 02895

Key Executives

Name Title Year Born
Ms. Karen Sue Lynch Pres, CEO & Director 1963
Mr. Shawn Michael Guertin Exec. VP & CFO 1964
Dr. Alan M. Lotvin M.D. Exec. VP & Pres of Pharmacy Services 1962
Mr. James David Clark Sr. VP, Controller & Chief Accounting Officer 1965
Mr. Tilak Mandadi Exec. VP & Chief Data, Digital and Technology Officer 1964
Mr. Larry McGrath Sr. VP of Bus. Devel. & Investor Relations NA
Mr. Thomas Michael Moriarty Exec. VP, Chief Policy & External Affairs Officer and Gen. Counsel 1964
Mr. David A. Falkowski Exec. VP & Chief Compliance Officer NA
Mr. Norman de Greve Chief Marketing Officer NA
Ms. Laurie P. Havanec Exec. VP & Chief People Officer 1961

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

We use cookies to help us improve, promote, and protect our services. By continuing to use this site, we assume you consent to our Cookies Policy. For more information, read our Privacy Policy and Terms and Conditions